News for Biofrontera AG (BFRA)

WOBURN, Mass., Nov. 22, 2024 (GLOBE NEWSWIRE) -- Biofrontera Inc. ( BFRI) (”œBiofrontera” or the ”œCompany”), a biopharmaceutical company specializing i

Biofrontera Inc. (BFRI) delivered earnings and revenue surprises of -17.81% and 18.15%, respectively, for the quarter ended September 2024. Do the numbers hold clues to what lies ahead for the stock?

**media[465508]**

First Phase 3 PDT study in patients with sBCC in the United States.Rigorous dual endpoints requiring complete clinical and cytological clearance of...

Biofrontera target cut to $16 from $25 on second-quarter results

“Photodynamic Therapy Devices Market” from 2024-2034 with covered segments By Product Type (Photosensitizer Drugs, Aminolevulinic Acid, Porphyrin...

Biofrontera Inc. (NASDAQ:NASDAQ:BFRI) Q1 2024 Earnings Conference Call May 16, 2024 10:00 AM ETCompany ParticipantsAndrew Barwicki - Barwicki Investor...

Shares of Jabil Inc. (NYSE: JBL) fell sharply during Friday’s session after the company reported financial second-quarter results and issued FY25 guidance below estimates.

May 31, 2023 / 12:00PM GMTOperator Good day, and welcome to the Biofrontera Reports Results for the First Quarter of 2023 Conference Call. (Operator Instruction

May 02, 2022 / 12:00PM GMTOperator Dear, ladies and gentlemen, welcome to the conference call of Biofrontera AG. At our customer's request, this conference will

Nov 18, 2021 / 01:00PM GMTOperator Dear, ladies and gentlemen, welcome to the Conference Call to Discuss the Q3 2021 Earnings Results. At our customers' request

Aug 20, 2021 / 12:00PM GMTOperator Yes, ladies and gentlemen, welcome to the conference call of Biofrontera AG. Per customers' request, this conference will be

Apr 21, 2020 / 12:00PM GMTOperator Dear, ladies and gentlemen, welcome to the conference call of Biofrontera AG to discuss full year 2019 financial results. At

Nov 19, 2019 / 01:00PM GMTOperator Dear, ladies and gentlemen, welcome to the conference call of Biofrontera AG. At our customersâ request, this conference wil

Shares of Fluor Corporation (NYSE: FLR) fell during Tuesday’s session following fourth-quarter results.

One of the primary growth drivers for the PDT market is the rising incidence of cancer and skin diseases globally. PDT is particularly effective in...

Gainers Gaucho Group Holdings, Inc. (NASDAQ: VINO) jumped 95.2% to $3.7280. Gaucho Group is planning to list two of its retail properties in Argentina, in San Rafael and Cordoba, for sale, priced at $2 million and $0.7 million respectively.

/PRNewswire/ -- According to a comprehensive research report by Brandessence Market Research (BMRC), "Photodynamic Therapy Market Overview, Component, Industry...

/PRNewswire/ -- The photodynamic therapy market size to grow by USD 2,053.68 million from 2022 to 2027, progressing at a CAGR of 8.22% during the forecast...